Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
AB „Amber Grid“, juridinio asmens kodas: 303090867. Adresas: Laisvės pr. 10, LT-04215 Vilnius, Lietuva. 2026 m. kovo 2 d. įvykusiame neeiliniame visuotiniame AB „Amber Grid“ akcininkų susirinkime...
-
Decisions adopted in the Extraordinary General Meeting of Shareholders of AB Amber Grid AB Amber Grid, legal entity code: 303090867. Address: Laisvės ave. 10, LT-04215 Vilnius, Lithuania. The...
-
Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Helicopter-Based Transportation Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Helicopter-Based Transportation...
-
ATHENS, Greece, March 02, 2026 (GLOBE NEWSWIRE) -- Imperial Petroleum Inc. is a ship-owning company providing petroleum products, crude oil and drybulk seaborne transportation services, announced...
-
VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its financial results for the three...
-
HANGZHOU, March 02, 2026 (GLOBE NEWSWIRE) -- Jiuzi Holdings, Inc. (Nasdaq: JZXN) ("Jiuzi" or the "Company") today announced that, following the successful completion of its $60 million private...
-
CHICAGO, March 02, 2026 (GLOBE NEWSWIRE) -- Automotive Mentoring Group (AMG) collaborated in a volunteer initiative alongside the SBB Research Group Foundation, which partners with local nonprofits...
-
ISLAMABAD, Pakistan , March 02, 2026 (GLOBE NEWSWIRE) -- ACE Money Transfer, one of the leading global remittance service providers, has entered into a strategic partnership with Askari Bank to...
-
Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Semiconductor Intellectual Property Market Report 2026" has been added to ResearchAndMarkets.com's offering. The semiconductor intellectual...
-
Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.